Bioactives of Momordica charantia as Potential Anti-Diabetic/Hypoglycemic Agents

B Xu, Z Li, T Zeng, J Zhan, S Wang, CT Ho, S Li - Molecules, 2022 - mdpi.com
Momordica charantia L., a member of the Curcubitaceae family, has traditionally been used
as herbal medicine and as a vegetable. Functional ingredients of M. charantia play …

JAK/STAT signaling in diabetic kidney disease

Y Liu, W Wang, J Zhang, S Gao, T Xu… - Frontiers in Cell and …, 2023 - frontiersin.org
Diabetic kidney disease (DKD) is the most important microvascular complication of diabetes
and the leading cause of end-stage renal disease (ESRD) worldwide. The Janus …

Nanomedicines for the management of diabetic nephropathy: present progress and prospects

P Paul, L Chacko, TK Dua, P Chakraborty… - Frontiers in …, 2023 - frontiersin.org
Diabetic nephropathy (DN) is a serious microvascular consequence of diabetes mellitus
(DM), posing an encumbrance to public health worldwide. Control over the onset and …

Role of Fenugreek, Cinnamon, Curcuma longa, Berberine and Momordica charantia in Type 2 Diabetes Mellitus Treatment: A Review

M Cortez-Navarrete, KG Pérez-Rubio… - Pharmaceuticals, 2023 - mdpi.com
Type 2 diabetes mellitus (T2DM) is a complex disease that has become a major global
health concern. Given the efficacy of antidiabetic drugs, pharmacological therapy is …

Suppression of sonic hedgehog pathway-based proliferation in glioblastoma cells by small-size silver nanoparticles in vitro

B Skóra, M Masicz, P Nowak, J Lachowska… - Archives of …, 2023 - Springer
Glioblastomas (GBs) are one of the most aggressive and invasive intracranial cancers.
Recently, it has been postulated that, among other factors, the hedgehog (HH) pathway may …

Gene expression profiling and protein analysis reveal suppression of the C-Myc oncogene and inhibition JAK/STAT and PI3K/AKT/mTOR signaling by thymoquinone …

B Almajali, MF Johan, AS Al-Wajeeh, WR Wan Taib… - Pharmaceuticals, 2022 - mdpi.com
Overexpression of c-Myc plays an essential role in leukemogenesis and drug resistance,
making c-Myc an attractive target for cancer therapy. However, targeting c-Myc directly is …

Extraction methods, multiple biological activities, and related mechanisms of Momordica charantia polysaccharide: A review

J Liu, Y Guo, J Sun, Y Lei, M Guo, L Wang - International Journal of …, 2024 - Elsevier
Abstract Momordica Charantia Polysaccharide (MCP) is a key bioactive compound derived
from bitter melon fruit. This review summarizes the advancements in MCP research …

Liraglutide Attenuates Diabetic Cardiomyopathy via the ILK/PI3K/AKT/PTEN Signaling Pathway in Rats with Streptozotocin-Induced Type 2 Diabetes Mellitus

SM Alobaid, RM Alshahrani, AS Alonazi… - Pharmaceuticals, 2024 - mdpi.com
One of the possible candidates for the treatment of diabetic cardiomyopathy is liraglutide, a
glucagon-like peptide-1 receptor (GLP1R) agonist. In this study, the impacts of liraglutide on …

Momordica charantia nanoparticles promote mitochondria biogenesis in the pancreas of diabetic-induced rats: gene expression study

OO Elekofehinti, OC Ayodele, O Iwaloye - Egyptian Journal of Medical …, 2021 - Springer
Background Mitochondria dysfunction is one of the clinical features of diabetes mellitus
(DM), which is a hallmark of insulin resistance (IR). This study investigates the therapeutic …

Screening of compounds from Nigerian antidiabetic plants as protein tyrosine phosphatase 1B inhibitor

F Olawale, K Olofinsan, O Iwaloye… - Computational …, 2022 - Elsevier
Several studies have established the antidiabetic properties of several traditional Nigerian
plants, but only limited studies have elucidated their mechanism of action. Protein tyrosine …